
To evaluate the effects of zzso (15 and 20 zzso on weight, zzso control, and blood pressure in zzso obese subjects with type 2 zzso 

A 12-month zzso prospective zzso zzso study was zzso It included 21 primary and secondary care centers in England, Canada, France, and zzso A total of 195 subjects zzso zzso with type 2 diabetes and a zzso zzso were zzso Changes were assessed in weight, blood pressure and resting heart rate, zzso zzso zzso and zzso 

zzso induced significant weight loss zzso zzso with both 15 zzso zzso zzso zzso zzso at 12 zzso and 20 zzso zzso zzso zzso zzso whereas zzso did not zzso zzso zzso zzso Weight zzso or zzso zzso was achieved by 14 and zzso of subjects receiving 15 and 20 zzso respectively, but by none given zzso zzso control improved in parallel with weight loss, and subjects who zzso or zzso zzso weight showed significant decreases in both zzso zzso zzso zzso P zzso and zzso plasma zzso zzso zzso P zzso HDL cholesterol increased slightly with the higher dose, whereas plasma zzso fell with both doses, especially in subjects with weight loss zzso or zzso zzso (a zzso decrease, P zzso Treatment was generally well zzso zzso treatment raised sitting zzso blood pressure zzso or zzso 5 zzso in a higher proportion of patients than did zzso zzso with 15 zzso zzso zzso with zzso P zzso but this effect was less evident in subjects who had a weight loss zzso or zzso zzso zzso Pulse rate increased significantly more with zzso zzso or zzso 10 zzso higher in zzso of treated patients versus zzso with zzso zzso zzso 

zzso can be an effective adjunct to zzso treatment in selected obese type 2 diabetic subjects and improves zzso control in individuals who lose zzso 

